In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer

Abstract Background Hypoxia is a characteristic of breast tumours indicating poor prognosis. Based on the assumption that those genes which are up-regulated under hypoxia in cell-lines are expected to be predictors of poor prognosis in clinical data, many signatures of poor prognosis were identified...

Full description

Bibliographic Details
Main Authors: Basel Abu-Jamous, Francesca M. Buffa, Adrian L. Harris, Asoke K. Nandi
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Molecular Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12943-017-0673-0
_version_ 1828526895411494912
author Basel Abu-Jamous
Francesca M. Buffa
Adrian L. Harris
Asoke K. Nandi
author_facet Basel Abu-Jamous
Francesca M. Buffa
Adrian L. Harris
Asoke K. Nandi
author_sort Basel Abu-Jamous
collection DOAJ
description Abstract Background Hypoxia is a characteristic of breast tumours indicating poor prognosis. Based on the assumption that those genes which are up-regulated under hypoxia in cell-lines are expected to be predictors of poor prognosis in clinical data, many signatures of poor prognosis were identified. However, it was observed that cell line data do not always concur with clinical data, and therefore conclusions from cell line analysis should be considered with caution. As many transcriptomic cell-line datasets from hypoxia related contexts are available, integrative approaches which investigate these datasets collectively, while not ignoring clinical data, are required. Results We analyse sixteen heterogeneous breast cancer cell-line transcriptomic datasets in hypoxia-related conditions collectively by employing the unique capabilities of the method, UNCLES, which integrates clustering results from multiple datasets and can address questions that cannot be answered by existing methods. This has been demonstrated by comparison with the state-of-the-art iCluster method. From this collection of genome-wide datasets include 15,588 genes, UNCLES identified a relatively high number of genes (>1000 overall) which are consistently co-regulated over all of the datasets, and some of which are still poorly understood and represent new potential HIF targets, such as RSBN1 and KIAA0195. Two main, anti-correlated, clusters were identified; the first is enriched with MYC targets participating in growth and proliferation, while the other is enriched with HIF targets directly participating in the hypoxia response. Surprisingly, in six clinical datasets, some sub-clusters of growth genes are found consistently positively correlated with hypoxia response genes, unlike the observation in cell lines. Moreover, the ability to predict bad prognosis by a combined signature of one sub-cluster of growth genes and one sub-cluster of hypoxia-induced genes appears to be comparable and perhaps greater than that of known hypoxia signatures. Conclusions We present a clustering approach suitable to integrate data from diverse experimental set-ups. Its application to breast cancer cell line datasets reveals new hypoxia-regulated signatures of genes which behave differently when in vitro (cell-line) data is compared with in vivo (clinical) data, and are of a prognostic value comparable or exceeding the state-of-the-art hypoxia signatures.
first_indexed 2024-12-11T21:30:22Z
format Article
id doaj.art-607aeb687fcf4adb860c943f3cb51b92
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-11T21:30:22Z
publishDate 2017-06-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-607aeb687fcf4adb860c943f3cb51b922022-12-22T00:50:11ZengBMCMolecular Cancer1476-45982017-06-0116111910.1186/s12943-017-0673-0In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancerBasel Abu-Jamous0Francesca M. Buffa1Adrian L. Harris2Asoke K. Nandi3Department of Electronic and Computer Engineering, Brunel University LondonCancer Research UK, Department of Oncology, Weatherall Institute of Molecular MedicineCancer Research UK, Department of Oncology, Weatherall Institute of Molecular MedicineDepartment of Electronic and Computer Engineering, Brunel University LondonAbstract Background Hypoxia is a characteristic of breast tumours indicating poor prognosis. Based on the assumption that those genes which are up-regulated under hypoxia in cell-lines are expected to be predictors of poor prognosis in clinical data, many signatures of poor prognosis were identified. However, it was observed that cell line data do not always concur with clinical data, and therefore conclusions from cell line analysis should be considered with caution. As many transcriptomic cell-line datasets from hypoxia related contexts are available, integrative approaches which investigate these datasets collectively, while not ignoring clinical data, are required. Results We analyse sixteen heterogeneous breast cancer cell-line transcriptomic datasets in hypoxia-related conditions collectively by employing the unique capabilities of the method, UNCLES, which integrates clustering results from multiple datasets and can address questions that cannot be answered by existing methods. This has been demonstrated by comparison with the state-of-the-art iCluster method. From this collection of genome-wide datasets include 15,588 genes, UNCLES identified a relatively high number of genes (>1000 overall) which are consistently co-regulated over all of the datasets, and some of which are still poorly understood and represent new potential HIF targets, such as RSBN1 and KIAA0195. Two main, anti-correlated, clusters were identified; the first is enriched with MYC targets participating in growth and proliferation, while the other is enriched with HIF targets directly participating in the hypoxia response. Surprisingly, in six clinical datasets, some sub-clusters of growth genes are found consistently positively correlated with hypoxia response genes, unlike the observation in cell lines. Moreover, the ability to predict bad prognosis by a combined signature of one sub-cluster of growth genes and one sub-cluster of hypoxia-induced genes appears to be comparable and perhaps greater than that of known hypoxia signatures. Conclusions We present a clustering approach suitable to integrate data from diverse experimental set-ups. Its application to breast cancer cell line datasets reveals new hypoxia-regulated signatures of genes which behave differently when in vitro (cell-line) data is compared with in vivo (clinical) data, and are of a prognostic value comparable or exceeding the state-of-the-art hypoxia signatures.http://link.springer.com/article/10.1186/s12943-017-0673-0Breast cancerCell linesHypoxiaCo-expressionCo-regulationGenome-wide analysis
spellingShingle Basel Abu-Jamous
Francesca M. Buffa
Adrian L. Harris
Asoke K. Nandi
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
Molecular Cancer
Breast cancer
Cell lines
Hypoxia
Co-expression
Co-regulation
Genome-wide analysis
title In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
title_full In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
title_fullStr In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
title_full_unstemmed In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
title_short In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
title_sort in vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
topic Breast cancer
Cell lines
Hypoxia
Co-expression
Co-regulation
Genome-wide analysis
url http://link.springer.com/article/10.1186/s12943-017-0673-0
work_keys_str_mv AT baselabujamous invitrodownregulatedhypoxiatranscriptomeisassociatedwithpoorprognosisinbreastcancer
AT francescambuffa invitrodownregulatedhypoxiatranscriptomeisassociatedwithpoorprognosisinbreastcancer
AT adrianlharris invitrodownregulatedhypoxiatranscriptomeisassociatedwithpoorprognosisinbreastcancer
AT asokeknandi invitrodownregulatedhypoxiatranscriptomeisassociatedwithpoorprognosisinbreastcancer